Translating discovery research into commercial products by Broglie. Richard
DuPont’s agriculture and Nutrition Platform consists of three business units: Pioneer 
Hi-Bred International, DuPont Crop Protection Products, and Solae, an alliance between 
DuPont and Bunge Limited formed to develop and market nutritious soy-protein products. 
These businesses develop products for customers all along the agricultural value chain, 
from seed- and crop-protection chemical inputs for growers, to novel grain traits for food, 
feed and fuel processors, to more healthy and nutritious food products for consumers. The 
platform is supported by two r&D organizations. The focus here is on Crop Genetics 
r&D, aimed at the development of biotechnology traits.
Increased Demands on agriculture
Growing needs for biobased, renewable fuels and materials will place a greater demand on 
agricultural productivity leading to the adoption of more intensive agricultural practices. 
to be successful under such conditions, farmers will require a suite of traits that protects 
crops from abiotic and biotic stresses, especially if economic conditions benefit mono-
cropping practices. trait combinations will be needed that protect crops from disease and 
help minimize risk to growers, that enhance crop productivity and genetic gain and that 
increase the end-use value of the harvested grain. Expression of such traits will be required 
at appropriate stages of plant growth and development to maximize effectiveness.





Our pipeline includes Optimum GAT, which provides new weed-
control opportunities, the Herculex insect-control traits, increased 
nutrient-use efficiency, grain traits and drought tolerance.
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Figure  shows traits that will provide growers with new and better options for weed 
and insect control. Our pipeline is robust and contains second- and third-generation 
traits that will follow in the marketplace after initial trait concepts are commercialized. 
Some specific examples include Optimum Gat, a trait that provides new weed-control 
opportunities and the Herculex insect-control family of traits. Other longer-term traits 
include disease resistance from transgenic and native sources, traits that increase nutrient-
use efficiency, grain traits for food, feed and fuel uses and drought tolerance.
Complementary approaches to trait Development
Currently we employ two complementary technical paths to develop traits: a conventional 
transgenic plant approach and the use of marker-assisted breeding to identify and stack 
genetically complex, native-trait loci. We also use map-based cloning strategies to identify 
the genes and pathways involved in conditioning such complex traits. Often stacking 
both transgenic and native traits is required in order to achieve a product concept that 
meets customer needs. For example, to develop improved feed traits, we are exploiting 
natural variations for certain grain components—such as increased digestibility—and 
Figure . Intensive agricultural production will demand traits for 
increased agricultural productivity.
Successful product development demands that traits are bred into 
the most elite, high-yielding germplasm.
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combining these loci with transgenic approaches that achieve a more balanced amino acid 
composition in the grain. Successful product development also demands that traits are 
bred into the most elite, high-yielding germplasm, and the use of molecular markers and 
other technologies like double haploids can be used in conjunction with contra-seasonal 
seed production to accelerate trait integration and breeding timelines. 
robust Project Management
In addition to a strong discovery platform, product development requires a robust proj-
ect-management system to ensure that resources are allocated optimally to advance traits 
rapidly through the product-development timeline. at Pioneer, we use a process called 
Stages and Gateways to provide a framework for project-advancement decisions. It is 
a gated discovery process that provides defined technical and commercial criteria that 
must be achieved for projects to move toward commercial development. Projects that 
have achieved proof-of-concept, have a clear intellectual property protection strategy, and 
have confirmed phenotypes in field and greenhouse trials advance to Phase 3 or advanced 
Development where field and laboratory data are assembled and submitted for regulatory 
approval, and extensive field-efficacy and breeding trials are conducted. advancement to 
Phase 3 signals an organizational commitment to commercialize a product and requires a 
significant increase in dedicated resources. New products with novel end-use applications 
require extensive product testing to confirm their value in-use and to quantify specific 
customer benefits. Such early application testing also provides data to support commu-
nications about consumer benefits.
Figure . Pipeline of biotechnology traits.
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Product Pipeline
as we look at our trait pipeline (Figure ), we can see a shift from traits conditioned by 
single genes, such as insect or herbicide resistance, to traits where combinations of mul-
tiple genetic loci and/or several transgenes are required to achieve product specifications. 
In some cases, several genes are required to introduce new pathway branches to produce 
beneficial seed-oil compositions, such as in the production of long chain omega-3 fatty 
acids in soybeans. as more success is achieved in producing such products with clear 
consumer health benefits, more education will be required to achieve consumer accep-
tance of these products.
Production of health-promoting omega-3 fatty acids in soybeans 
represents a technical accomplishment achieved by introducing 
five to seven new biochemical steps.
Figure 3 shows our family of healthy oil products. On the market today is a non-trans-
genic, low-linolenic soybean oil product used in food-ingredient applications to reduce 
the amount of trans-fatty acids in the diet. This product will be followed in the market 
by a high oleic acid soybean product produced by reducing the amount of delta- de-
Figure 3. Soybean oil product pipeline.
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saturase in the seed and preventing the conversion of oleic acid to linoleic acid. High oleic 
soybean oil is extremely stable, eliminating the need for hydrogenation. Combinations 
of high oleic acid and high stearic acid traits provide novel, healthy oils for solid-fat food 
applications. Production of health-promoting omega-3 fatty acids in soybeans represents 
a technical accomplishment achieved by introducing five to seven new biochemical steps 
required for the production of long-chain omega-3 fatty acids. This trait has achieved 
the proof-of-concept milestone in our pipeline. The commercialization of such a com-
plex trait will require more investment of resources to ensure trait stability, agronomic 
performance and public acceptance than, for example, the introduction of second- and 
third-generation insect-resistance traits, where first-generation products already enjoy 
wide commercial acceptance.
In Conclusion
Several key components are required to translate discovery research into successful biotech-
nology-based products: a robust, technology-enhanced trait-discovery platform; a rigorous 
process for advancing products through the product-development process, increasing the 
probability of technical and commercial success at each step; a strong and experienced 
regulatory sciences program that provides high-quality data for agency approval; and a 
clear understanding of unmet customer needs.
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Dr. Broglie has held a number of research-leadership positions at DuPont, 
and has made significant contributions toward the discovery of traits for modi-
fied soybean and canola oils and disease resistance in corn, soybean, wheat and 
rice. He has served on the board of directors of InterMountain Canola, a limited 
partnership between DuPont and DNaP, and as business development manager 
linking internal research programs with strategic business partnerships. 
In his present role, Broglie has responsiblity for developing and implement-
ing r&D strategies in India and China to access talent globally and to develop 
products for emerging markets in Southeast asia. 
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